Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sufentanil NanoTab PCA System in Knee Replacement
NCT00859313Phase 2Completed
- Sponsor
- Talphera
- Start
- Apr 2009
- Primary completion
- Aug 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of sufentanil in postoperative pain, sponsored by Talphera. Started Apr 2009; status: completed.
02
Drugs
sufentanil
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT00859313.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00859313.